| Literature DB >> 18467109 |
Qiang Wang1, Maoying Chen, Huawei Zhu, Jie Zhang, Hao Fang, Binghe Wang, Wenfang Xu.
Abstract
A series of novel l-lysine derivatives were designed, synthesized, and assayed for their inhibitory activities on amino-peptidase N (APN)/CD13 and matrix metalloproteinase-2 (MMP-2). The preliminary biological test showed that most of the compounds displayed a high inhibitory activity against MMP-2 and a low activity against APN except compound B6 which exhibited good potency (IC(50)=13.2microM) similar with APN inhibitor Bestatin (IC(50)=15.5microM), and could be used as lead compound in the future.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18467109 DOI: 10.1016/j.bmc.2008.04.012
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641